Literature DB >> 27134299

Diagnostics and Therapy for Malignant (Degenerate) Colon Endometriosis - Three Case Reports.

R Schutz1, J Woziwodzki2, K-W Schweppe1.   

Abstract

Malignant degeneration of colon endometriosis is a very rare event. We report here on three cases. A 48-year-old woman with a 10-year history of endometriosis was treated for a rectal adenocarcinoma, a 61-year-old G1P1, who was operated at the age of 40 years for ovarian endometriosis and again at the age of 53 years for an endometriosis-associated endometroid ovarian carcinoma, presented for therapy for a lymph node recurrence of the ovarian cancer and, secondly, due to a malignantly degenerated rectum-sigmoid colon endometriosis; furthermore a 54-year old woman with a 21-year history of endometriosis was operated for malignant colon endometriosis. The tumour occurred during an adjuvant anti-oestrogen treatment with an aromatase inhibitor following surgical and radiotherapy for breast cancer. In all cases a radical cancer operation was followed by adjuvant chemotherapy and in one case with an additional radiotherapy. In the follow-up periods of 18 months, 2 and 5 years, respectively, all women remained free of recurrences. Although this is not a randomised controlled study due to the rare occurrence of such cases, a radical operation followed by individualised adjuvant therapy appears to be the treatment of choice.

Entities:  

Keywords:  bowel endometriosis; endometriosis-associated carcinoma; malignant degeneration

Year:  2016        PMID: 27134299      PMCID: PMC4846413          DOI: 10.1055/s-0041-109769

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  9 in total

1.  Prognostic analysis of ovarian cancer associated with endometriosis.

Authors:  Sanjeev Kumar; Adnan Munkarah; Haitham Arabi; Sudeshna Bandyopadhyay; Assaad Semaan; Kinda Hayek; Gunjal Garg; Robert Morris; Rouba Ali-Fehmi
Journal:  Am J Obstet Gynecol       Date:  2010-11-11       Impact factor: 8.661

2.  Ovarian and extraovarian endometriosis-associated cancer.

Authors:  Susan C Modesitt; Guillermo Tortolero-Luna; Jubilee B Robinson; David M Gershenson; Judith K Wolf
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

3.  Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases.

Authors:  R K Yantiss; P B Clement; R H Young
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

Review 4.  Role of endometriosis in cancer and tumor development.

Authors:  Lillian Marie Swiersz
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

5.  Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.

Authors:  M Erzen; S Rakar; B Klancnik; K Syrjänen; B Klancar
Journal:  Gynecol Oncol       Date:  2001-10       Impact factor: 5.482

6.  Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.

Authors:  Justin Cuff; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

7.  The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.

Authors:  Hirotaka Kajihara; Yoshihiko Yamada; Hiroshi Shigetomi; Yumi Higashiura; Hiroshi Kobayashi
Journal:  Int J Gynecol Pathol       Date:  2012-07       Impact factor: 2.762

8.  Endometriosis as a prognostic factor for cancer survival.

Authors:  A Melin; C Lundholm; N Malki; M-L Swahn; P Sparen; A Bergqvist
Journal:  Int J Cancer       Date:  2010-12-02       Impact factor: 7.396

Review 9.  Endometriosis and the development of malignant tumours of the pelvis. A review of literature.

Authors:  Toon Van Gorp; Frederic Amant; Patrick Neven; Ignace Vergote; Phillipe Moerman
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-04       Impact factor: 5.237

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.